{"nbformat":4,"nbformat_minor":0,"metadata":{"colab":{"provenance":[],"toc_visible":true},"kernelspec":{"name":"python3","display_name":"Python 3"},"language_info":{"name":"python"}},"cells":[{"cell_type":"code","source":["!pip install rdkit\n","!pip install networkx\n","!pip install torch-geometric"],"metadata":{"id":"ffMvmC9p6cKb"},"execution_count":null,"outputs":[]},{"cell_type":"code","execution_count":null,"metadata":{"id":"ZD4lXNCX1rRH"},"outputs":[],"source":["import torch\n","import torch.nn as nn\n","import gdown\n","import pandas as pd\n","import torch\n","from rdkit import Chem\n","from torch_geometric.data import Data, Batch\n","import networkx as nx\n","import matplotlib.pyplot as plt\n","from torch_geometric.utils import to_networkx"]},{"cell_type":"markdown","source":["# DSI Pickle"],"metadata":{"id":"x9UbXBH8vY-O"}},{"cell_type":"code","source":["import torch\n","from torch_geometric.nn import GCNConv, NNConv, BatchNorm\n","from torch_geometric.data import Data\n","\n","class DSIGNN(torch.nn.Module):\n","    def __init__(self, in_channels, hidden_channels, out_channels, edge_channels):\n","        super(DSIGNN, self).__init__()\n","        self.conv1 = NNConv(in_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, in_channels * hidden_channels))\n","        self.bn1 = BatchNorm(hidden_channels)\n","\n","        self.conv1b = NNConv(hidden_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, hidden_channels * hidden_channels))\n","        self.bn1b = BatchNorm(hidden_channels)\n","\n","        self.conv2 = NNConv(hidden_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, hidden_channels * hidden_channels))\n","        self.bn2 = BatchNorm(hidden_channels)\n","\n","        self.fc1 = torch.nn.Linear(hidden_channels, hidden_channels)\n","        self.fc2 = torch.nn.Linear(hidden_channels, out_channels)\n","        self.dropout = torch.nn.Dropout(p=0.5)\n","\n","    def l2_regularization(self):\n","        l2_reg = 0\n","        for param in self.parameters():\n","            l2_reg += torch.sum(param ** 2)\n","        return l2_reg\n","\n","    def forward(self, graph):\n","        v=graph.x\n","        edge_index = graph.edge_index\n","        e = graph.edge_attr\n","        indices = graph.indices\n","\n","        v1 = v[torch.tensor(indices[\"node\"][0][0])]\n","\n","        e1 = e[torch.tensor(indices[\"edge\"][0][0])]\n","        e2 = e[torch.tensor(indices[\"edge\"][0][1])]\n","\n","        eidx1 = edge_index[:, torch.tensor(indices[\"edge_index\"][0][0])]\n","        eidx2 = edge_index[:, torch.tensor(indices[\"edge_index\"][0][1])]\n","\n","        graph1 = self.conv1(v1, eidx1, e1)\n","        graph1 = self.bn1(graph1)\n","        graph1 = torch.nn.functional.elu(graph1)\n","\n","        graph1 = self.conv1b(graph1, eidx1, e1)\n","        graph1 = self.bn1(graph1)\n","        graph1 = torch.nn.functional.elu(graph1)\n","\n","\n","        combined_nodes = torch.cat((graph1, torch.zeros(1, 40)), dim=0)\n","        v2 = self.conv2(combined_nodes, eidx2, e2)\n","        v2 = self.bn2(v2)\n","        v2 = torch.nn.functional.elu(v2)\n","        v2 = self.dropout(v2[-1])\n","\n","        v2 = self.fc1(v2)\n","        v2 = torch.nn.functional.elu(v2)\n","\n","        v2 = self.fc2(v2)\n","        v2 = torch.nn.functional.elu(v2)\n","\n","        return v2"],"metadata":{"id":"Igq6OTWO78UH"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["import pickle\n","from google.colab import drive\n","\n","drive.mount('/content/drive')\n","\n","# Load the model\n","with open('/content/drive/MyDrive/CS 566/Pickle Files/dsi_model.pkl', 'rb') as f:\n","    dsi_model = pickle.load(f)\n","\n","# Put the model in evaluation mode\n","dsi_model.eval()"],"metadata":{"id":"gosE3NkD4JiY"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["# DDI Pickle"],"metadata":{"id":"PAkpCy1Vvwdi"}},{"cell_type":"code","source":["class DDIGNN(torch.nn.Module):\n","    def __init__(self, in_channels, hidden_channels, out_channels, edge_channels):\n","        super(DDIGNN, self).__init__()\n","        self.conv1 = NNConv(in_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, in_channels * hidden_channels))\n","        self.bn1 = BatchNorm(hidden_channels)\n","\n","        self.conv1b = NNConv(hidden_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, hidden_channels * hidden_channels))\n","        self.bn1b = BatchNorm(hidden_channels)\n","\n","        self.conv2 = NNConv(in_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, in_channels * hidden_channels))\n","        self.bn2 = BatchNorm(hidden_channels)\n","\n","        self.conv2b = NNConv(hidden_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, hidden_channels * hidden_channels))\n","        self.bn2b = BatchNorm(hidden_channels)\n","\n","        self.conv3 = NNConv(hidden_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, hidden_channels * hidden_channels))\n","        self.bn3 = BatchNorm(hidden_channels)\n","\n","        self.fc1 = torch.nn.Linear(hidden_channels, hidden_channels)\n","        self.dropout = torch.nn.Dropout(p=0.5)\n","\n","        self.fc2 = torch.nn.Linear(hidden_channels, out_channels)\n","\n","    def l2_regularization(self):\n","        l2_reg = 0\n","        for param in self.parameters():\n","            l2_reg += torch.sum(param ** 2)\n","        return l2_reg\n","\n","    def forward(self, graph):\n","        v=graph.x\n","        edge_index = graph.edge_index\n","        e = graph.edge_attr\n","        indices = graph.indices\n","\n","        v1 = v[torch.tensor(indices[\"node\"][0][0])]\n","        v2 = v[torch.tensor(indices[\"node\"][0][1])]\n","\n","        e1 = e[torch.tensor(indices[\"edge\"][0][0])]\n","        e2 = e[torch.tensor(indices[\"edge\"][0][1])]\n","        e3 = e[torch.tensor(indices[\"edge\"][0][2])]\n","\n","        eidx1 = edge_index[:, torch.tensor(indices[\"edge_index\"][0][0])]\n","        eidx2 = torch.sub(edge_index[:, torch.tensor(indices[\"edge_index\"][0][1])], v1.shape[0])\n","        eidx3 = edge_index[:, torch.tensor(indices[\"edge_index\"][0][2])]\n","\n","        graph1 = self.conv1(v1, eidx1, e1)\n","        graph1 = self.bn1(graph1)\n","        graph1 = torch.nn.functional.elu(graph1)\n","\n","        graph1 = self.conv1b(graph1, eidx1, e1)\n","        graph1 = self.bn1b(graph1)\n","        graph1 = torch.nn.functional.elu(graph1)\n","\n","        graph2 = self.conv2(v2, eidx2, e2)\n","        graph2 = self.bn2(graph2)\n","        graph2 = torch.nn.functional.elu(graph2)\n","\n","        graph2 = self.conv2b(graph2, eidx2, e2)\n","        graph2 = self.bn2b(graph2)\n","        graph2 = torch.nn.functional.elu(graph2)\n","\n","        combined_nodes = torch.cat((graph1, graph2, torch.zeros(1, graph1.shape[1])), dim=0)\n","        v3 = self.conv3(combined_nodes, eidx3, e3)\n","        v3 = self.bn3(v3)\n","        v3 = torch.nn.functional.elu(v3)\n","        v3 = self.dropout(v3[-1])\n","\n","        v3 = self.fc1(v3)\n","        v3 = torch.nn.functional.elu(v3)\n","\n","        v3 = self.fc2(v3)\n","        v3 = torch.nn.functional.elu(v3)\n","\n","        return v3"],"metadata":{"id":"O6qcgVo08PCs"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["with open('/content/drive/MyDrive/CS 566/Pickle Files/ddi_model.pkl', 'rb') as f:\n","    ddi_model = pickle.load(f)\n","\n","# Put the model in evaluation mode\n","ddi_model.eval()"],"metadata":{"id":"qWeYxc-eAddT"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["# Effectiveness Pickle"],"metadata":{"id":"PYOGOzuGv2S2"}},{"cell_type":"code","source":["class EffectiveGNN(torch.nn.Module):\n","    def __init__(self, in_channels, hidden_channels, out_channels, edge_channels):\n","        super(EffectiveGNN, self).__init__()\n","        self.conv1 = NNConv(in_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, in_channels * hidden_channels))\n","        self.bn1 = BatchNorm(hidden_channels)\n","\n","        self.conv1b = NNConv(hidden_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, hidden_channels * hidden_channels))\n","        self.bn1b = BatchNorm(hidden_channels)\n","\n","        self.conv2 = NNConv(hidden_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, hidden_channels * hidden_channels))\n","        self.bn2 = BatchNorm(hidden_channels)\n","\n","        self.fc1 = torch.nn.Linear(hidden_channels, hidden_channels)\n","        self.fc2 = torch.nn.Linear(hidden_channels, out_channels)\n","        self.dropout = torch.nn.Dropout(p=0.5)\n","\n","    def l2_regularization(self):\n","        l2_reg = 0\n","        for param in self.parameters():\n","            l2_reg += torch.sum(param ** 2)\n","        return l2_reg\n","\n","    def forward(self, graph):\n","        v=graph.x\n","        edge_index = graph.edge_index\n","        e = graph.edge_attr\n","        indices = graph.indices\n","\n","        v1 = v[torch.tensor(indices[\"node\"][0][0])]\n","\n","        e1 = e[torch.tensor(indices[\"edge\"][0][0])]\n","        e2 = e[torch.tensor(indices[\"edge\"][0][1])]\n","\n","        eidx1 = edge_index[:, torch.tensor(indices[\"edge_index\"][0][0])]\n","        eidx2 = edge_index[:, torch.tensor(indices[\"edge_index\"][0][1])]\n","\n","        graph1 = self.conv1(v1, eidx1, e1)\n","        graph1 = self.bn1(graph1)\n","        graph1 = torch.nn.functional.elu(graph1)\n","\n","        graph1 = self.conv1b(graph1, eidx1, e1)\n","        graph1 = self.bn1b(graph1)\n","        graph1 = torch.nn.functional.elu(graph1)\n","\n","        combined_nodes = torch.cat((graph1, torch.zeros(1, graph1.shape[1])), dim=0)\n","\n","        graph2 = self.conv2(combined_nodes, eidx2, e2)\n","        graph2 = self.bn2(graph2)\n","        graph2 = torch.nn.functional.elu(graph2)\n","\n","        graph2 = self.dropout(graph2[-1])\n","        graph2 = self.fc1(graph2)\n","        graph2 = torch.nn.functional.elu(graph2)\n","\n","        graph2 = self.fc2(graph2)\n","        graph2 = torch.nn.functional.elu(graph2)\n","\n","        return graph2"],"metadata":{"id":"xQoJuApOAvoi"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["drive.mount('/content/drive', force_remount=True)\n","\n","with open('/content/drive/MyDrive/CS 566/Pickle Files/effectiveness_model.pkl', 'rb') as f:\n","    effectiveness_model = pickle.load(f)\n","\n","# Put the model in evaluation mode\n","effectiveness_model.eval()"],"metadata":{"id":"gW_KlWD8X0eQ"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["# Synergy Pickle"],"metadata":{"id":"MkNWPgAkwjRw"}},{"cell_type":"code","source":["import torch\n","from torch_geometric.nn import GCNConv, NNConv, BatchNorm\n","from torch_geometric.data import Data\n","\n","class SynergyGNN(torch.nn.Module):\n","    def __init__(self, in_channels, hidden_channels, out_channels, edge_channels):\n","        super(SynergyGNN, self).__init__()\n","        self.conv1 = NNConv(in_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, in_channels * hidden_channels))\n","        self.bn1 = BatchNorm(hidden_channels)\n","\n","        self.conv1b = NNConv(hidden_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, hidden_channels * hidden_channels))\n","        self.bn1b = BatchNorm(hidden_channels)\n","\n","        self.conv2 = NNConv(in_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, in_channels * hidden_channels))\n","        self.bn2 = BatchNorm(hidden_channels)\n","\n","        self.conv2b = NNConv(hidden_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, hidden_channels * hidden_channels))\n","        self.bn2b = BatchNorm(hidden_channels)\n","\n","        self.conv3 = NNConv(hidden_channels, hidden_channels, nn=torch.nn.Linear(edge_channels, hidden_channels * hidden_channels))\n","        self.bn3 = BatchNorm(hidden_channels)\n","\n","        self.dropout = torch.nn.Dropout(p=0.5)\n","\n","        self.fc2 = torch.nn.Linear(hidden_channels, out_channels)\n","\n","    def l2_regularization(self):\n","        l2_reg = 0\n","        for param in self.parameters():\n","            l2_reg += torch.sum(param ** 2)\n","        return l2_reg\n","\n","    def forward(self, graph):\n","        v=graph.x\n","        edge_index = graph.edge_index\n","        e = graph.edge_attr\n","        indices = graph.indices\n","\n","        v1 = v[torch.tensor(indices[\"node\"][0][0])]\n","        v2 = v[torch.tensor(indices[\"node\"][0][1])]\n","\n","        e1 = e[torch.tensor(indices[\"edge\"][0][0])]\n","        e2 = e[torch.tensor(indices[\"edge\"][0][1])]\n","        e3 = e[torch.tensor(indices[\"edge\"][0][2])]\n","\n","        eidx1 = edge_index[:, torch.tensor(indices[\"edge_index\"][0][0])]\n","        eidx2 = torch.sub(edge_index[:, torch.tensor(indices[\"edge_index\"][0][1])], v1.shape[0])\n","        eidx3 = edge_index[:, torch.tensor(indices[\"edge_index\"][0][2])]\n","\n","        graph1 = self.conv1(v1, eidx1, e1)\n","        graph1 = self.bn1(graph1)\n","        graph1 = torch.nn.functional.elu(graph1)\n","\n","        graph1 = self.conv1b(graph1, eidx1, e1)\n","        graph1 = self.bn1b(graph1)\n","        graph1 = torch.nn.functional.elu(graph1)\n","\n","        graph2 = self.conv2(v2, eidx2, e2)\n","        graph2 = self.bn2(graph2)\n","        graph2 = torch.nn.functional.elu(graph2)\n","\n","        graph2 = self.conv2b(graph2, eidx2, e2)\n","        graph2 = self.bn2b(graph2)\n","        graph2 = torch.nn.functional.elu(graph2)\n","\n","        combined_nodes = torch.cat((graph1, graph2, torch.zeros(1, graph1.shape[1])), dim=0)\n","        v3 = self.conv3(combined_nodes, eidx3, e3)\n","        v3 = self.bn3(v3)\n","        v3 = torch.nn.functional.elu(v3)\n","        v3 = self.dropout(v3[-1])\n","\n","        v3 = self.fc2(v3)\n","        v3 = torch.nn.functional.elu(v3)\n","\n","        return v3"],"metadata":{"id":"Eit7hX0PYIxL"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["with open('/content/drive/MyDrive/CS 566/Pickle Files/catalyst_model.pkl', 'rb') as f:\n","    catalyst_model = pickle.load(f)\n","\n","# Put the model in evaluation mode\n","catalyst_model.eval()"],"metadata":{"id":"JDF8OHrtclxk"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["import pandas as pd"],"metadata":{"id":"Htn7PRXGm667"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["df = pd.read_csv('/content/drive/MyDrive/CS 566/Notebooks/three_merged.csv')"],"metadata":{"id":"WLqYSIIJmdnX"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["df=df.drop(['Unnamed: 0', 'Drug_ID_y', 'Drug1_ID_1', 'Drug2_ID_1', 'Drug2_ID_2', 'Drug1_ID_2' ], axis=1)"],"metadata":{"id":"_MokSajxounR"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["df=df.rename(columns={\"Drug_ID_x\": \"Drug_ID\", \"Y_x\": \"Solubility\", \"Drug_canon\": \"Drug_standardized\", \"Y_y\":\"Binding_Affinity\", \"Y_1\":\"Drug_Interaction\", \"Y.1_1\":\"Description\", \"Y.1_2\":\"Side_Effect\" })"],"metadata":{"id":"UU5Uo2TWpCyx"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["import pandas as pd\n","harsh = pd.read_csv('/content/drive/MyDrive/CS 566/Notebooks/Updated_effectiveness.csv')\n","\n","mydict = harsh.set_index('Target_ID')['Target_encoded'].to_dict()\n","df['Target_encoded'] = df['Target_ID'].map(mydict)"],"metadata":{"id":"LofD4RaIRL22"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["def molecule_to_graph(molecule):\n","    num_atoms = molecule.GetNumAtoms()\n","    x = torch.tensor([atom_feature_vector(atom) for atom in molecule.GetAtoms()], dtype=torch.float)\n","    edge_index = []\n","    edge_attr = []\n","    for bond in molecule.GetBonds():\n","        edge_index.extend([[bond.GetBeginAtomIdx(), bond.GetEndAtomIdx()], [bond.GetEndAtomIdx(), bond.GetBeginAtomIdx()]])\n","        edge_attr.extend([bond_feature_vector(bond), bond_feature_vector(bond)])\n","    edge_index = torch.tensor(edge_index, dtype=torch.long).t().contiguous()\n","    edge_attr = torch.tensor(edge_attr, dtype=torch.float)\n","    return Data(x=x, edge_index=edge_index, edge_attr=edge_attr)\n","\n","def atom_feature_vector(atom):\n","    return [atom.GetAtomicNum(), atom.GetDegree(), atom.GetHybridization()]\n","\n","def bond_feature_vector(bond):\n","    return [bond.GetBondTypeAsDouble(), bond.IsInRing()]\n","\n","def visualize(graph):\n","    nx_graph = to_networkx(graph, to_undirected=True)\n","\n","    fig = plt.figure(figsize=(10, 10))\n","    pos = nx.spring_layout(nx_graph)\n","\n","    nx.draw_networkx(nx_graph, pos, with_labels=True, node_size=500, font_size=12, font_weight='bold')\n","\n","    if 'edge_attr' in next(iter(nx_graph.edges(data=True)))[-1]:\n","        edge_labels = {(u, v): d['edge_attr'] for u, v, d in nx_graph.edges(data=True)}\n","        nx.draw_networkx_edge_labels(nx_graph, pos, edge_labels=edge_labels, font_size=10)\n","\n","    plt.axis('off')\n","    plt.show()"],"metadata":{"id":"3epwELaL6MB-"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["# DSI Predictions"],"metadata":{"id":"ibZWcuEECxm3"}},{"cell_type":"code","source":["import numpy as np\n","graphs1 = []\n","\n","for _, row in df.iterrows():\n","    try:\n","        idx_dict = {}\n","        if isinstance(row['Drug'], str):\n","            molecule = Chem.MolFromSmiles(row['Drug'])\n","        graph = molecule_to_graph(molecule)\n","\n","        required_feature_size = graph.x.shape[1]  # The total number of features per node\n","\n","        # Initialize a vector of zeros with the required_feature_size\n","        # Since there is no 'Y' column, we use only zeros\n","        ddi_score_features = torch.zeros(1, required_feature_size)\n","\n","        ddi_score_node_index = graph.x.shape[0]\n","\n","        combined_x = torch.cat([graph.x, ddi_score_features], dim=0)\n","        combined_x_idx = [[], []]\n","        combined_x_idx[0] = np.arange(0, graph.x.shape[0])  # graph 1 node indices\n","        combined_x_idx[1] = np.arange(graph.x.shape[0], graph.x.shape[0] + 1)  # index for the additional zeros\n","\n","        idx_dict[\"node\"] = combined_x_idx\n","\n","        # Creating additional edges connecting the new node to all existing nodes\n","        additional_edge_index = torch.cat([\n","            torch.tensor([[i, ddi_score_node_index] for i in range(graph.x.shape[0])])], dim=0).t().contiguous()\n","\n","        # Assuming all additional edges have the same attributes, such as a weight of 1\n","        additional_edge_attr = torch.ones((additional_edge_index.shape[1], graph.edge_attr.shape[1]), dtype=torch.float)\n","\n","        combined_edge_index = torch.cat([graph.edge_index, additional_edge_index], dim=1)\n","        combined_edge_index_idx = [[], []]\n","        combined_edge_index_idx[0] = np.arange(0, graph.edge_index.shape[1])  # Original edges' indices\n","        combined_edge_index_idx[1] = np.arange(graph.edge_index.shape[1], graph.edge_index.shape[1] + additional_edge_index.shape[1])  # New edges' indices\n","\n","        idx_dict[\"edge_index\"] = combined_edge_index_idx\n","\n","        combined_edge_attr = torch.cat([graph.edge_attr, additional_edge_attr], dim=0)\n","        combined_edge_attr_idx = [[], []]\n","        combined_edge_attr_idx[0] = np.arange(0, graph.edge_attr.shape[0])  # Original edge attributes' indices\n","        combined_edge_attr_idx[1] = np.arange(graph.edge_attr.shape[0], graph.edge_attr.shape[0] + additional_edge_attr.shape[0])  # New edge attributes' indices\n","\n","        idx_dict[\"edge\"] = combined_edge_attr_idx\n","\n","        # Create the final graph data object with the combined nodes, edges, and attributes\n","        combined_graph = Data(x=combined_x, edge_index=combined_edge_index, edge_attr=combined_edge_attr, y=ddi_score_features)\n","        combined_graph.indices = idx_dict\n","        graphs1.append(combined_graph)\n","\n","    except Exception as e:\n","        print(f\"Error processing row: {e}\")\n","        continue\n","\n"],"metadata":{"id":"5zV1f9ZY6qc2"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["from torch_geometric.loader import DataLoader\n","\n","graph1_loader = DataLoader(graphs1, batch_size=1, shuffle=False,  drop_last=False)"],"metadata":{"id":"J3WOoNHIBh_c"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["device = torch.device('cuda' if torch.cuda.is_available() else 'cpu')\n","dsi_model.to(device)"],"metadata":{"id":"Vo-mzKcbB2Yg"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["dsi_predictions = []\n","with torch.no_grad():\n","    for d in graph1_loader:\n","        d = d.to(device)\n","        output = dsi_model(d)\n","        dsi_predictions.extend(output.cpu().numpy())"],"metadata":{"id":"_EIEWhQlBxVo"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["df['Solubility_pred']=dsi_predictions\n","print(set(dsi_predictions))"],"metadata":{"id":"6M0dGKV8dWLq"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["# DDI Predictions"],"metadata":{"id":"1aeoMs5bhce5"}},{"cell_type":"code","source":["import torch\n","from rdkit import Chem\n","from torch_geometric.data import Data\n","import numpy as np\n","# Define function placeholders (atom_feature_vector, bond_feature_vector, molecule_to_graph) here\n","graphs2 = []\n","indices2 = []\n","count = 0\n","\n","for _, row in df.iterrows():\n","    idx_dict = {}\n","    try:\n","        molecule1 = Chem.MolFromSmiles(row['Drug1'])\n","        molecule2 = Chem.MolFromSmiles(row['Drug2'])\n","\n","        # Check if molecules are None (indicating parsing failure)\n","        if molecule1 is None or molecule2 is None:\n","            print(\"Parsing error: Skipping row due to invalid SMILES.\")\n","            continue\n","\n","        graph1 = molecule_to_graph(molecule1)\n","        graph2 = molecule_to_graph(molecule2)\n","\n","        ddi_features = torch.zeros((1, 2), dtype=torch.float)\n","\n","        ddi_features_node_index = graph1.x.shape[0] + graph2.x.shape[0]\n","        pad_size = graph1.x.shape[1] - ddi_features.shape[1]\n","\n","        ddi_features_padded = torch.cat([ddi_features,torch.zeros((ddi_features.shape[0],pad_size))],dim=1)\n","\n","        combined_x = torch.cat([graph1.x, graph2.x, ddi_features_padded])\n","\n","        combined_x_idx = [[], [], []]\n","        combined_x_idx[0] = np.arange(0,graph1.x.shape[0]) # graph 1 node indices\n","        combined_x_idx[1] = np.arange(graph1.x.shape[0],graph1.x.shape[0]+graph2.x.shape[0]) # graph 2 node indices\n","        combined_x_idx[2] = np.arange(graph1.x.shape[0]+graph2.x.shape[0],graph1.x.shape[0]+graph2.x.shape[0]+1) # y node index\n","\n","\n","        idx_dict[\"node\"] = combined_x_idx\n","\n","        # Create edges between each node in graph1 and the \"Catalyst Score\" node\n","        graph1_to_y_edge_index = torch.cat([\n","            torch.tensor([[i, ddi_features_node_index] for i in range(graph1.x.shape[0])])\n","        ], dim=0).t().contiguous()\n","\n","        '''\n","            Create edges between each node in graph2 and the \"Catalyst Score\" node. Note that a graph.x.shape[0] offset\n","            is required so that the edge indices are offset\n","        '''\n","        graph2_to_y_edge_index = torch.cat([\n","            torch.tensor([[i + graph1.x.shape[0], ddi_features_node_index] for i in range(graph2.x.shape[0])])\n","        ], dim=0).t().contiguous()\n","\n","        # Combine the edge indices\n","        combined_edge_index = torch.cat([graph1.edge_index, graph2.edge_index + graph1.x.shape[0], graph1_to_y_edge_index, graph2_to_y_edge_index], dim=1)\n","\n","        combined_edge_index_idx = [[], [], []]\n","        combined_edge_index_idx[0] = np.arange(0,graph1.edge_index.shape[1]) # graph 1 edge index' indices\n","        combined_edge_index_idx[1] = np.arange(graph1.edge_index.shape[1],graph1.edge_index.shape[1]+graph2.edge_index.shape[1]) # graph 2 edge index' indices\n","        combined_edge_index_idx[2] = np.arange(graph1.edge_index.shape[1]+graph2.edge_index.shape[1],\n","                            graph1.edge_index.shape[1]+graph2.edge_index.shape[1]+graph1_to_y_edge_index.shape[1]+graph2_to_y_edge_index.shape[1]) # y edge index' index\n","\n","        idx_dict[\"edge_index\"] = combined_edge_index_idx\n","\n","        # Edge connections from every other node to Y node\n","        graph1_to_y_edge_attr = torch.ones((graph1_to_y_edge_index.shape[1], graph1.edge_attr.shape[1]), dtype=torch.float)\n","        graph2_to_y_edge_attr = torch.ones((graph2_to_y_edge_index.shape[1], graph2.edge_attr.shape[1]), dtype=torch.float)\n","\n","        # Combine the edge attributes\n","        combined_edge_attr = torch.cat([graph1.edge_attr, graph2.edge_attr, graph1_to_y_edge_attr, graph2_to_y_edge_attr])\n","\n","        combined_edge_attr_idx = [[], [], []]\n","        combined_edge_attr_idx[0] = np.arange(0,graph1.edge_attr.shape[0]) # graph 1 edge attr' indices\n","        combined_edge_attr_idx[1] = np.arange(graph1.edge_attr.shape[0],graph1.edge_attr.shape[0]+graph2.edge_attr.shape[0]) # graph 2 edge attr' indices\n","        combined_edge_attr_idx[2] = np.arange(graph1.edge_attr.shape[0]+graph2.edge_attr.shape[0],\n","                            graph1.edge_attr.shape[0]+graph2.edge_attr.shape[0]+graph1_to_y_edge_attr.shape[0]+graph2_to_y_edge_attr.shape[0]) # y edge attr' index\n","\n","        idx_dict[\"edge\"] = combined_edge_attr_idx\n","\n","        # Create the combined graph\n","        combined_graph = Data(x=combined_x, edge_index=combined_edge_index, edge_attr=combined_edge_attr, y=ddi_features)\n","        graphs2.append(combined_graph)\n","        indices2.append(idx_dict)\n","\n","    except Exception as e:\n","        continue  # Skip this row and proceed to the next one\n","\n","\n","\n","# Call the function with your data\n","# process_data(your_data)\n"],"metadata":{"id":"UH98hGVf_sV8"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["data2 = []\n","for graph, index in zip(graphs2, indices2):\n","    graph.indices = index\n","    data2.append(graph)\n","\n","graph2_loader = DataLoader(data2, batch_size=1, shuffle=False,  drop_last=False)"],"metadata":{"id":"0i-XMsIbixpn"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["device = torch.device('cuda' if torch.cuda.is_available() else 'cpu')\n","ddi_model.to(device)"],"metadata":{"id":"hH-3gdITjZwC"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["ddi_predictions = []\n","with torch.no_grad():\n","    for d in graph2_loader:\n","        d = d.to(device)\n","        output = ddi_model(d)\n","        ddi_predictions.extend(output.cpu().numpy())"],"metadata":{"id":"tWX66gxcjbmz"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["def chunk_list(lst, chunk_size):\n","    return [lst[i:i + chunk_size] for i in range(0, len(lst), chunk_size)]\n","\n","# Chunking the list\n","chunked_list = chunk_list(ddi_predictions, 2)\n","\n","# Creating a DataFrame from the chunked list\n","new_df = pd.DataFrame(chunked_list, columns=['Y_1_pred', 'Y_2_pred'])\n","\n","# Appending the new DataFrame to the existing DataFrame\n","df['Y_1_pred'] = new_df['Y_1_pred']\n","df['Y_2_pred'] = new_df['Y_2_pred']"],"metadata":{"id":"kFOJ8gi6pDbx"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["# Effectiveness Predictions"],"metadata":{"id":"reCpAbRsj2Ca"}},{"cell_type":"code","source":["import numpy as np\n","import torch\n","from rdkit import Chem\n","from torch_geometric.data import Data\n","\n","def target_mapping(target):\n","  #to do\n","  pass\n","\n","graphs3 = []\n","indices3 = []\n","\n","for _, row in df.iterrows():\n","    idx_dict = {}\n","    if isinstance(row['Drug'], str):\n","        molecule = Chem.MolFromSmiles(row['Drug'])\n","        graph = molecule_to_graph(molecule)\n","\n","        required_feature_size = 1  # The total number of features per node\n","\n","        # Create a feature vector for the \"Catalyst Score\" node\n","        # Initialize a vector of zeros with the required_feature_size\n","        catalyst_score_features = torch.zeros(1, required_feature_size)\n","        # catalyst_score_features[0, 0] = row['Y'] -- replaced with zero\n","        catalyst_score_node_index = graph.x.shape[0]\n","\n","        pad_size = graph.x.shape[1] - catalyst_score_features.shape[1]\n","        catalyst_score_features_padded = torch.cat([catalyst_score_features, torch.zeros((catalyst_score_features.shape[0], pad_size))], dim=1)\n","\n","        combined_x = torch.cat([graph.x, catalyst_score_features_padded], dim=0)\n","\n","        combined_x_idx = [[], []]\n","        combined_x_idx[0] = np.arange(0, graph.x.shape[0])  # graph 1 node indices\n","        combined_x_idx[1] = np.arange(graph.x.shape[0], graph.x.shape[0]+1)  # y index\n","\n","        idx_dict[\"node\"] = combined_x_idx\n","\n","        additional_edge_index = torch.cat([\n","            torch.tensor([[i, catalyst_score_node_index] for i in range(graph.x.shape[0])]),\n","        ], dim=0).t().contiguous()\n","\n","        additional_edge_attr = torch.ones((additional_edge_index.shape[1], graph.edge_attr.shape[1]), dtype=torch.float)\n","\n","        combined_edge_index = torch.cat([graph.edge_index, additional_edge_index], dim=1)\n","\n","        combined_edge_index_idx = [[], []]\n","        combined_edge_index_idx[0] = np.arange(0, graph.edge_index.shape[1])  # graph 1 edge index' indices\n","        combined_edge_index_idx[1] = np.arange(graph.edge_index.shape[1],\n","                                              graph.edge_index.shape[1] + additional_edge_index.shape[1])  # y edge index' index\n","\n","        idx_dict[\"edge_index\"] = combined_edge_index_idx\n","\n","        combined_edge_attr = torch.cat([graph.edge_attr, additional_edge_attr], dim=0)\n","        combined_edge_attr_idx = [[], []]\n","        combined_edge_attr_idx[0] = np.arange(0, graph.edge_attr.shape[0])  # graph 1 edge attr' indices\n","        combined_edge_attr_idx[1] = np.arange(graph.edge_attr.shape[0],\n","                                              graph.edge_attr.shape[0] + additional_edge_attr.shape[0])  # y edge attr' index\n","\n","        idx_dict[\"edge\"] = combined_edge_attr_idx\n","        combined_graph = Data(x=combined_x, edge_index=combined_edge_index, edge_attr=combined_edge_attr, y=catalyst_score_features)\n","        combined_graph.target = torch.Tensor([[row['Target_encoded']]])\n","\n","        graphs3.append(combined_graph)\n","        indices3.append(idx_dict)\n"],"metadata":{"id":"0co1vKIYl3xa"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["data3 = []\n","for graph, index in zip(graphs3, indices3):\n","    graph.indices = index\n","    data3.append(graph)\n","\n","graph3_loader = DataLoader(data3, batch_size=1, shuffle=False,  drop_last=False)"],"metadata":{"id":"IkxVg9zOj95c"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["device = torch.device('cuda' if torch.cuda.is_available() else 'cpu')\n","effectiveness_model.to(device)"],"metadata":{"id":"ZQ303uuDkHdJ"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["effectiveness_predictions = []\n","with torch.no_grad():\n","    for d in graph3_loader:\n","        d = d.to(device)\n","        output = effectiveness_model(d)\n","        effectiveness_predictions.extend(output.cpu().numpy())"],"metadata":{"id":"ca_NN6fZkL9b"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["df['Binding_Affinity_pred']=np.exp(effectiveness_predictions)"],"metadata":{"id":"iDTuuujaeElS"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["# Catalyst Predictions"],"metadata":{"id":"KRwk1LbMl9lc"}},{"cell_type":"code","source":["import numpy as np\n","import torch\n","from rdkit import Chem\n","from torch_geometric.data import Data\n","\n","graphs4 = []\n","indices4 = []\n","for _, row in df.iterrows():\n","    idx_dict = {}\n","    # Convert SMILES to molecule objects\n","    molecule1 = Chem.MolFromSmiles(row['Drug1'])\n","    molecule2 = Chem.MolFromSmiles(row['Drug2'])\n","\n","    # Convert molecules to graph representations\n","    graph1 = molecule_to_graph(molecule1)\n","    graph2 = molecule_to_graph(molecule2)\n","\n","    # Create the \"Catalyst Score\" node\n","    num_features = 6  # Number of features you originally had\n","    catalyst_score_features = torch.zeros((1, num_features), dtype=torch.float)\n","    catalyst_score_node_index = graph1.x.shape[0] + graph2.x.shape[0]\n","\n","    # Pad the node features of graph1 and graph2 to match the size of the \"Catalyst Score\" node features\n","    pad_size = catalyst_score_features.shape[1] - graph1.x.shape[1]\n","    graph1_x_padded = torch.cat([graph1.x, torch.zeros((graph1.x.shape[0], pad_size))], dim=1)\n","    graph2_x_padded = torch.cat([graph2.x, torch.zeros((graph2.x.shape[0], pad_size))], dim=1)\n","\n","    # Combine the padded node features of graph1, graph2, and the \"Catalyst Score\" node\n","    combined_x = torch.cat([graph1_x_padded, graph2_x_padded, catalyst_score_features])\n","\n","    combined_x_idx = [[], [], []]\n","    combined_x_idx[0] = np.arange(0,graph1.x.shape[0]) # graph 1 node indices\n","    combined_x_idx[1] = np.arange(graph1.x.shape[0],graph1.x.shape[0]+graph2.x.shape[0]) # graph 2 node indices\n","    combined_x_idx[2] = np.arange(graph1.x.shape[0]+graph2.x.shape[0],graph1.x.shape[0]+graph2.x.shape[0]+1) # y node index\n","\n","    idx_dict[\"node\"] = combined_x_idx\n","\n","    # Create edges between each node in graph1 and the \"Catalyst Score\" node\n","    graph1_to_y_edge_index = torch.cat([\n","        torch.tensor([[i, catalyst_score_node_index] for i in range(graph1.x.shape[0])])\n","    ], dim=0).t().contiguous()\n","\n","    '''\n","        Create edges between each node in graph2 and the \"Catalyst Score\" node. Note that a graph.x.shape[0] offset\n","        is required so that the edge indices are offset\n","    '''\n","    graph2_to_y_edge_index = torch.cat([\n","        torch.tensor([[i + graph1.x.shape[0], catalyst_score_node_index] for i in range(graph2.x.shape[0])])\n","    ], dim=0).t().contiguous()\n","\n","    # Combine the edge indices\n","    combined_edge_index = torch.cat([graph1.edge_index, graph2.edge_index + graph1.x.shape[0], graph1_to_y_edge_index, graph2_to_y_edge_index], dim=1)\n","\n","    combined_edge_index_idx = [[], [], []]\n","    combined_edge_index_idx[0] = np.arange(0,graph1.edge_index.shape[1]) # graph 1 edge index' indices\n","    combined_edge_index_idx[1] = np.arange(graph1.edge_index.shape[1],graph1.edge_index.shape[1]+graph2.edge_index.shape[1]) # graph 2 edge index' indices\n","    combined_edge_index_idx[2] = np.arange(graph1.edge_index.shape[1]+graph2.edge_index.shape[1],\n","                        graph1.edge_index.shape[1]+graph2.edge_index.shape[1]+graph1_to_y_edge_index.shape[1]+graph2_to_y_edge_index.shape[1]) # y edge index' index\n","\n","    idx_dict[\"edge_index\"] = combined_edge_index_idx\n","\n","    # Edge connections from every other node to Y node\n","    graph1_to_y_edge_attr = torch.ones((graph1_to_y_edge_index.shape[1], graph1.edge_attr.shape[1]), dtype=torch.float)\n","    graph2_to_y_edge_attr = torch.ones((graph2_to_y_edge_index.shape[1], graph2.edge_attr.shape[1]), dtype=torch.float)\n","\n","    # Combine the edge attributes\n","    combined_edge_attr = torch.cat([graph1.edge_attr, graph2.edge_attr, graph1_to_y_edge_attr, graph2_to_y_edge_attr])\n","\n","    combined_edge_attr_idx = [[], [], []]\n","    combined_edge_attr_idx[0] = np.arange(0,graph1.edge_attr.shape[0]) # graph 1 edge attr' indices\n","    combined_edge_attr_idx[1] = np.arange(graph1.edge_attr.shape[0],graph1.edge_attr.shape[0]+graph2.edge_attr.shape[0]) # graph 2 edge attr' indices\n","    combined_edge_attr_idx[2] = np.arange(graph1.edge_attr.shape[0]+graph2.edge_attr.shape[0],\n","                        graph1.edge_attr.shape[0]+graph2.edge_attr.shape[0]+graph1_to_y_edge_attr.shape[0]+graph2_to_y_edge_attr.shape[0]) # y edge attr' index\n","\n","    idx_dict[\"edge\"] = combined_edge_attr_idx\n","\n","    # Create the combined graph\n","    combined_graph = Data(x=combined_x, edge_index=combined_edge_index, edge_attr=combined_edge_attr, y=catalyst_score_features)\n","    graphs4.append(combined_graph)\n","    indices4.append(idx_dict)\n","\n"],"metadata":{"id":"cthE9Fq0Zzt5"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["data4 = []\n","for graph, index in zip(graphs4, indices4):\n","    graph.indices = index\n","    data4.append(graph)\n","\n","graph4_loader = DataLoader(data4, batch_size=1, shuffle=False,  drop_last=False)"],"metadata":{"id":"ZBOdNgEkmGw4"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["device = torch.device('cuda' if torch.cuda.is_available() else 'cpu')\n","catalyst_model.to(device)"],"metadata":{"id":"2NLlotNvmPMa"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["catalyst_predictions = []\n","with torch.no_grad():\n","    for d in graph4_loader:\n","        d = d.to(device)\n","        output = catalyst_model(d)\n","        catalyst_predictions.extend(output.cpu().numpy())"],"metadata":{"id":"QJ2V9u-FmTeU"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["chunked_list1 = chunk_list(catalyst_predictions, 6)\n","\n","# Creating a DataFrame from the chunked list\n","new_df = pd.DataFrame(chunked_list1, columns=['CSS_pred', 'Synergy_ZIP_pred', 'Synergy_Bliss_pred', 'Synergy_Loewe_pred', 'Synergy_HSA_pred', 'Synergy_pred'])\n","\n","# Appending the new DataFrame to the existing DataFrame\n","df['CSS_pred'] = new_df['CSS_pred']\n","df['Synergy_ZIP_pred'] = new_df['Synergy_ZIP_pred']\n","df['Synergy_Bliss_pred'] = new_df['Synergy_Bliss_pred']\n","df['Synergy_Loewe_pred'] = new_df['Synergy_Loewe_pred']\n","df['Synergy_HSA_pred'] = new_df['Synergy_HSA_pred']\n","df['Synergy_pred'] = new_df['Synergy_pred']"],"metadata":{"id":"CswSByS0q5Bx"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["df['Y_1_pred'] = df['Y_1_pred'].round().astype(int)\n","df['Y_2_pred'] = df['Y_2_pred'].round().astype(int)"],"metadata":{"id":"OrpHRphvsAQW"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["# Joins"],"metadata":{"id":"fQusRY6_z00f"}},{"cell_type":"code","source":["!pip install PubChemPy\n","\n","import pubchempy as pcp\n","\n","def get_common_name(smiles):\n","    try:\n","        compounds = pcp.get_compounds(smiles, 'smiles')\n","        # Get the first compound and its common name from synonyms\n","        if compounds:\n","            synonyms = compounds[0].synonyms\n","            if synonyms:\n","                return synonyms[0]  # Return the first synonym as the common name\n","            else:\n","                return \"No common name found\"\n","        else:\n","            return \"No compound found\"\n","    except Exception as e:\n","        return str(e)"],"metadata":{"id":"xeGxNjUGsnmj"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["get_common_name(df['Drug1'][0])"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":35},"id":"bWdxN6vNvjKv","executionInfo":{"status":"ok","timestamp":1714150172389,"user_tz":420,"elapsed":2388,"user":{"displayName":"Akhil Krishna Reddy","userId":"05401649090299346256"}},"outputId":"7865d32c-3a17-4fe5-d5a0-e5916abc6e82"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["'palmitic acid'"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"string"}},"metadata":{},"execution_count":39}]},{"cell_type":"code","source":["df['Drug_1_common_name'] = df['Drug1'].apply(get_common_name)"],"metadata":{"id":"QUAYHUQxtKG4"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["df['Drug_2_common_name'] = df['Drug2'].apply(get_common_name)"],"metadata":{"id":"G7bD2Zvpx8GH"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["ddi_mapping = pd.read_csv('/content/drive/MyDrive/CS 566/Notebooks/DDI_Rishabh_Mapping_Y1_Y2.csv')\n","eff_mapping = pd.read_csv('/content/drive/MyDrive/CS 566/Notebooks/target_mapping_effectiveness_dataset.csv')"],"metadata":{"id":"iu4Svi_7yHNa"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["mydict1 = ddi_mapping.set_index('Y_1')['Y_1_definition'].to_dict()\n","\n","df['Y_1_definition'] = df['Y_1_pred'].map(mydict1)"],"metadata":{"id":"f70ctwkyzSMf"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["mydict2 = ddi_mapping.set_index('Y_2')['Y_2_definition'].to_dict()\n","\n","df['Y_2_definition'] = df['Y_2_pred'].map(mydict2)"],"metadata":{"id":"ighxFSJV1KI_"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["import requests\n","\n","def get_protein_sequence(protein_id):\n","\n","    url = f\"https://rest.uniprot.org/uniprotkb/{protein_id}.fasta\"\n","    response = requests.get(url)\n","\n","    if response.status_code == 200:\n","        return response.text\n","    else:\n","        return \"Error: Unable to retrieve data, please check the protein ID and your connection.\""],"metadata":{"id":"tgD0RZU91Ulx"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["df['Target_info'] = df['Target_ID'].apply(get_protein_sequence)"],"metadata":{"id":"sRymsRxt19gi"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["df.columns"],"metadata":{"id":"DOAQRetn0-xp"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["df.to_csv('/content/drive/MyDrive/CS 566/output.csv', index=False)\n"],"metadata":{"id":"Q_6WI0yR2xKz"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["user = \"patient\"\n","prompt = f\"I am a {user}. These are the lab results - \"\n","\n","for index, row in df.iterrows():\n","    # Effectiveness\n","    sample_prompt = prompt + f\"The effectiveness of {row['Drug_1_common_name']} for {row['Target_info']} is {row['Binding_Affinity_pred']}. \"\n","\n","    # DDI\n","    sample_prompt += f\"The Drug-Drug Interaction between {row['Drug_1_common_name']} and {row['Drug_2_common_name']} is {row['Y_1_definition']}, and the side effect of having Drug 2 with Drug 1 is {row['Y_2_definition']}. \"\n","\n","    # DSI\n","    sample_prompt += f\"The solubility of {row['Drug_1_common_name']} in water is {row['Solubility_pred']}. \"\n","\n","    # Catalyst\n","    sample_prompt += f\"CSS measures the drug combination sensitivity and is derived using relative IC50 values of compounds\"\n","    sample_prompt += f\"and the area under their dose-response curves. The other four metrics capture the synergy between the\"\n","    sample_prompt += f\"two drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response from\"\n","    sample_prompt += f\"the expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),\"\n","    sample_prompt += f\"Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between {row['Drug_1_common_name']} and {row['Drug_2_common_name']}\"\n","    sample_prompt += f\"is given by CSS - {row['CSS_pred']}, Synergy - {row['Synergy_pred']}, ZIP - {row['Synergy_ZIP_pred']}, LOEWE - {row['Synergy_Loewe_pred']}, \"\n","    sample_prompt += f\"HSA - {row['Synergy_HSA_pred']} and BLISS - {row['Synergy_Bliss_pred']}. \\n\"\n","\n","    # Stitch them together\n","    sample_prompt += f\"In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\"\n","\n","    print(sample_prompt)\n","    print('\\n\\n\\n')"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"puH1dGor9_6K","executionInfo":{"status":"ok","timestamp":1714150780914,"user_tz":420,"elapsed":743,"user":{"displayName":"Akhil Krishna Reddy","userId":"05401649090299346256"}},"outputId":"d21a855d-be47-42ea-d2cd-90ee949e0643"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["I am a patient. These are the lab results - The effectiveness of palmitic acid for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between palmitic acid and Dabigatran etexilate is The absorption of #Drug2 can be decreased when combined with #Drug1., and the side effect of having Drug 2 with Drug 1 is acute pancreatitis. The solubility of palmitic acid in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between palmitic acid and Dabigatran etexilateis given by CSS - 16.086740493774414, Synergy - -0.6028023958206177, ZIP - 0.40339475870132446, LOEWE - -0.8912323117256165, HSA - 0.9833912253379822 and BLISS - 0.18516480922698975. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Etravirine is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Etravirineis given by CSS - 9.797019958496094, Synergy - -0.3775864243507385, ZIP - 0.2602419853210449, LOEWE - -0.7190299034118652, HSA - 0.6151654124259949 and BLISS - 0.12568478286266327. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Armodafinil is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Armodafinilis given by CSS - 11.824996948242188, Synergy - -0.5683897733688354, ZIP - 0.2973453998565674, LOEWE - -0.7941439151763916, HSA - 0.7281013131141663 and BLISS - 0.15697133541107178. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Midostaurin is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Midostaurinis given by CSS - 6.7507452964782715, Synergy - 0.05969006568193436, ZIP - 0.20420047640800476, LOEWE - -0.5505098700523376, HSA - 0.44668376445770264 and BLISS - 0.0838676318526268. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Atazanavir is #Drug1 may decrease the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acromegaly. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Atazanaviris given by CSS - 5.6233038902282715, Synergy - 0.23096603155136108, ZIP - 0.18297810852527618, LOEWE - -0.46278709173202515, HSA - 0.3862808048725128 and BLISS - 0.07694865018129349. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Quinine is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Quinineis given by CSS - 10.698416709899902, Synergy - -0.4710472822189331, ZIP - 0.27673524618148804, LOEWE - -0.7553108334541321, HSA - 0.6653653383255005 and BLISS - 0.13959191739559174. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and 2-phenylcyclopropan-1-amine is #Drug1 may increase the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is premature separation of placenta. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and 2-phenylcyclopropan-1-amineis given by CSS - 13.852383613586426, Synergy - -0.7006953954696655, ZIP - 0.3344261050224304, LOEWE - -0.8491700291633606, HSA - 0.8409877419471741 and BLISS - 0.1882418990135193. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and isoniazid is #Drug1 may increase the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is premature separation of placenta. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and isoniazidis given by CSS - 13.852383613586426, Synergy - -0.7006953954696655, ZIP - 0.3344261050224304, LOEWE - -0.8491700291633606, HSA - 0.8409877419471741 and BLISS - 0.1882418990135193. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Cobicistat is The absorption of #Drug2 can be decreased when combined with #Drug1., and the side effect of having Drug 2 with Drug 1 is acute pancreatitis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Cobicistatis given by CSS - 5.235536098480225, Synergy - 0.2871892750263214, ZIP - 0.1756284534931183, LOEWE - -0.42856472730636597, HSA - 0.3657023012638092 and BLISS - 0.07543785125017166. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Ticagrelor is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Ticagreloris given by CSS - 8.001141548156738, Synergy - -0.13962292671203613, ZIP - 0.22736868262290955, LOEWE - -0.6299126744270325, HSA - 0.5151668787002563 and BLISS - 0.0980859100818634. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and ketoconazole is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and ketoconazoleis given by CSS - 8.001141548156738, Synergy - -0.13962292671203613, ZIP - 0.22736868262290955, LOEWE - -0.6299126744270325, HSA - 0.5151668787002563 and BLISS - 0.0980859100818634. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and irbesartan is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and irbesartanis given by CSS - 8.895502090454102, Synergy - -0.2676088809967041, ZIP - 0.2437441349029541, LOEWE - -0.6773662567138672, HSA - 0.5649555921554565 and BLISS - 0.11177443712949753. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and amiodarone is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and amiodaroneis given by CSS - 9.120893478393555, Synergy - -0.29680323600769043, ZIP - 0.24786902964115143, LOEWE - -0.6883286237716675, HSA - 0.5775089859962463 and BLISS - 0.11525233834981918. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and valsartan is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and valsartanis given by CSS - 8.895502090454102, Synergy - -0.2676088809967041, ZIP - 0.2437441349029541, LOEWE - -0.6773662567138672, HSA - 0.5649555921554565 and BLISS - 0.11177443712949753. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and nefazodone is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and nefazodoneis given by CSS - 8.67010498046875, Synergy - -0.23720240592956543, ZIP - 0.2396189421415329, LOEWE - -0.6660181879997253, HSA - 0.5524014830589294 and BLISS - 0.10829634219408035. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and VERAPAMIL is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and VERAPAMILis given by CSS - 8.67010498046875, Synergy - -0.23720240592956543, ZIP - 0.2396189421415329, LOEWE - -0.6660181879997253, HSA - 0.5524014830589294 and BLISS - 0.10829634219408035. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and sulfamethoxazole is #Drug1 may increase the ototoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is abscess. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and sulfamethoxazoleis given by CSS - 12.275577545166016, Synergy - -0.6021105647087097, ZIP - 0.3055875301361084, LOEWE - -0.8078922033309937, HSA - 0.7531914114952087 and BLISS - 0.16392171382904053. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and pyrimethamine is #Drug1 may increase the ototoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is abscess. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and pyrimethamineis given by CSS - 12.275577545166016, Synergy - -0.6021105647087097, ZIP - 0.3055875301361084, LOEWE - -0.8078922033309937, HSA - 0.7531914114952087 and BLISS - 0.16392171382904053. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Delavirdine is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Delavirdineis given by CSS - 8.895502090454102, Synergy - -0.2676088809967041, ZIP - 0.2437441349029541, LOEWE - -0.6773662567138672, HSA - 0.5649555921554565 and BLISS - 0.11177443712949753. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Crizotinib is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Crizotinibis given by CSS - 9.34627628326416, Synergy - -0.32483363151550293, ZIP - 0.25199365615844727, LOEWE - -0.6989182233810425, HSA - 0.5900617837905884 and BLISS - 0.11873001605272293. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and leflunomide is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and leflunomideis given by CSS - 11.824996948242188, Synergy - -0.5683897733688354, ZIP - 0.2973453998565674, LOEWE - -0.7941439151763916, HSA - 0.7281013131141663 and BLISS - 0.15697133541107178. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and dihydroergotamine is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and dihydroergotamineis given by CSS - 6.7507452964782715, Synergy - 0.05969006568193436, ZIP - 0.20420047640800476, LOEWE - -0.5505098700523376, HSA - 0.44668376445770264 and BLISS - 0.0838676318526268. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Lapatinib is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Lapatinibis given by CSS - 7.239928722381592, Synergy - -0.01949894428253174, ZIP - 0.21331532299518585, LOEWE - -0.5836189389228821, HSA - 0.4732668399810791 and BLISS - 0.08851643651723862. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and RUCAPARIB is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and RUCAPARIBis given by CSS - 10.698416709899902, Synergy - -0.4710472822189331, ZIP - 0.27673524618148804, LOEWE - -0.7553108334541321, HSA - 0.6653653383255005 and BLISS - 0.13959191739559174. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Ziprasidone is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Ziprasidoneis given by CSS - 9.797019958496094, Synergy - -0.3775864243507385, ZIP - 0.2602419853210449, LOEWE - -0.7190299034118652, HSA - 0.6151654124259949 and BLISS - 0.12568478286266327. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and celecoxib is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and celecoxibis given by CSS - 10.247733116149902, Synergy - -0.4262169599533081, ZIP - 0.26848918199539185, LOEWE - -0.7377973794937134, HSA - 0.6402666568756104 and BLISS - 0.13263875246047974. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Crisaborole is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Crisaboroleis given by CSS - 11.824996948242188, Synergy - -0.5683897733688354, ZIP - 0.2973453998565674, LOEWE - -0.7941439151763916, HSA - 0.7281013131141663 and BLISS - 0.15697133541107178. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and rabeprazole is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and rabeprazoleis given by CSS - 10.473078727722168, Synergy - -0.4490879774093628, ZIP - 0.2726123332977295, LOEWE - -0.7467055320739746, HSA - 0.6528162956237793 and BLISS - 0.1361154317855835. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and tolbutamide is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and tolbutamideis given by CSS - 12.050292015075684, Synergy - -0.5855931043624878, ZIP - 0.30146658420562744, LOEWE - -0.80113685131073, HSA - 0.7406467199325562 and BLISS - 0.1604466289281845. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Teriflunomide is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Teriflunomideis given by CSS - 11.824996948242188, Synergy - -0.5683897733688354, ZIP - 0.2973453998565674, LOEWE - -0.7941439151763916, HSA - 0.7281013131141663 and BLISS - 0.15697133541107178. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and citalopram is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and citalopramis given by CSS - 10.698416709899902, Synergy - -0.4710472822189331, ZIP - 0.27673524618148804, LOEWE - -0.7553108334541321, HSA - 0.6653653383255005 and BLISS - 0.13959191739559174. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Lopinavir is #Drug1 may decrease the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acromegaly. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Lopinaviris given by CSS - 6.305581569671631, Synergy - 0.12902799248695374, ZIP - 0.19585271179676056, LOEWE - -0.5178647041320801, HSA - 0.42270803451538086 and BLISS - 0.08058071881532669. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and SAQUINAVIR is #Drug1 may decrease the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acromegaly. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and SAQUINAVIRis given by CSS - 5.889526844024658, Synergy - 0.19171938300132751, ZIP - 0.18801166117191315, LOEWE - -0.48503434658050537, HSA - 0.4004558324813843 and BLISS - 0.0781944990158081. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Topiroxostat is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Topiroxostatis given by CSS - 11.824996948242188, Synergy - -0.5683897733688354, ZIP - 0.2973453998565674, LOEWE - -0.7941439151763916, HSA - 0.7281013131141663 and BLISS - 0.15697133541107178. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and moclobemide is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and moclobemideis given by CSS - 12.050292015075684, Synergy - -0.5855931043624878, ZIP - 0.30146658420562744, LOEWE - -0.80113685131073, HSA - 0.7406467199325562 and BLISS - 0.1604466289281845. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Imatinib is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Imatinibis given by CSS - 7.795658588409424, Synergy - -0.10796523094177246, ZIP - 0.22359056770801544, LOEWE - -0.6180034875869751, HSA - 0.503792405128479 and BLISS - 0.09522394835948944. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and nelfinavir is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and nelfinaviris given by CSS - 7.239928722381592, Synergy - -0.01949894428253174, ZIP - 0.21331532299518585, LOEWE - -0.5836189389228821, HSA - 0.4732668399810791 and BLISS - 0.08851643651723862. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and gemfibrozil is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and gemfibrozilis given by CSS - 12.050292015075684, Synergy - -0.5855931043624878, ZIP - 0.30146658420562744, LOEWE - -0.80113685131073, HSA - 0.7406467199325562 and BLISS - 0.1604466289281845. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Isavuconazonium is #Drug1 may decrease the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acromegaly. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Isavuconazoniumis given by CSS - 5.6233038902282715, Synergy - 0.23096603155136108, ZIP - 0.18297810852527618, LOEWE - -0.46278709173202515, HSA - 0.3862808048725128 and BLISS - 0.07694865018129349. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and omeprazole is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and omeprazoleis given by CSS - 10.698416709899902, Synergy - -0.4710472822189331, ZIP - 0.27673524618148804, LOEWE - -0.7553108334541321, HSA - 0.6653653383255005 and BLISS - 0.13959191739559174. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Posaconazole is #Drug1 may decrease the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acromegaly. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Posaconazoleis given by CSS - 5.6233038902282715, Synergy - 0.23096603155136108, ZIP - 0.18297810852527618, LOEWE - -0.46278709173202515, HSA - 0.3862808048725128 and BLISS - 0.07694865018129349. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Darunavir is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Darunaviris given by CSS - 7.601211071014404, Synergy - -0.07746672630310059, ZIP - 0.22000494599342346, LOEWE - -0.606343150138855, HSA - 0.49307188391685486 and BLISS - 0.09270337224006653. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and nicardipine is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and nicardipineis given by CSS - 8.219289779663086, Synergy - -0.1725497841835022, ZIP - 0.2313677817583084, LOEWE - -0.6421101093292236, HSA - 0.5272917747497559 and BLISS - 0.1013396605849266. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and fluoxetine is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and fluoxetineis given by CSS - 11.149070739746094, Synergy - -0.5123744606971741, ZIP - 0.2849801480770111, LOEWE - -0.771653950214386, HSA - 0.6904615759849548 and BLISS - 0.14654427766799927. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and sertraline is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and sertralineis given by CSS - 11.599696159362793, Synergy - -0.5504722595214844, ZIP - 0.29322394728660583, LOEWE - -0.7869049310684204, HSA - 0.7155553698539734 and BLISS - 0.15349584817886353. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and isradipine is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and isradipineis given by CSS - 10.022379875183105, Synergy - -0.40239620208740234, ZIP - 0.2643657326698303, LOEWE - -0.7285758256912231, HSA - 0.6277163624763489 and BLISS - 0.12916187942028046. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and topiramate is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and topiramateis given by CSS - 11.149070739746094, Synergy - -0.5123744606971741, ZIP - 0.2849801480770111, LOEWE - -0.771653950214386, HSA - 0.6904615759849548 and BLISS - 0.14654427766799927. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Fosamprenavir is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Fosamprenaviris given by CSS - 7.416380405426025, Synergy - -0.04801523685455322, ZIP - 0.21658706665039062, LOEWE - -0.594893753528595, HSA - 0.48292112350463867 and BLISS - 0.09048029035329819. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Vitamin D3 is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Vitamin D3is given by CSS - 9.797019958496094, Synergy - -0.3775864243507385, ZIP - 0.2602419853210449, LOEWE - -0.7190299034118652, HSA - 0.6151654124259949 and BLISS - 0.12568478286266327. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Zucapsaicin is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Zucapsaicinis given by CSS - 11.149070739746094, Synergy - -0.5123744606971741, ZIP - 0.2849801480770111, LOEWE - -0.771653950214386, HSA - 0.6904615759849548 and BLISS - 0.14654427766799927. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and chloramphenicol is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and chloramphenicolis given by CSS - 11.599696159362793, Synergy - -0.5504722595214844, ZIP - 0.29322394728660583, LOEWE - -0.7869049310684204, HSA - 0.7155553698539734 and BLISS - 0.15349584817886353. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Atomoxetine is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Atomoxetineis given by CSS - 11.824996948242188, Synergy - -0.5683897733688354, ZIP - 0.2973453998565674, LOEWE - -0.7941439151763916, HSA - 0.7281013131141663 and BLISS - 0.15697133541107178. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and venlafaxine is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and venlafaxineis given by CSS - 11.599696159362793, Synergy - -0.5504722595214844, ZIP - 0.29322394728660583, LOEWE - -0.7869049310684204, HSA - 0.7155553698539734 and BLISS - 0.15349584817886353. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and sildenafil is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and sildenafilis given by CSS - 8.67010498046875, Synergy - -0.23720240592956543, ZIP - 0.2396189421415329, LOEWE - -0.6660181879997253, HSA - 0.5524014830589294 and BLISS - 0.10829634219408035. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Telaprevir is #Drug1 may decrease the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acromegaly. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Telapreviris given by CSS - 5.889526844024658, Synergy - 0.19171938300132751, ZIP - 0.18801166117191315, LOEWE - -0.48503434658050537, HSA - 0.4004558324813843 and BLISS - 0.0781944990158081. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Telithromycin is The absorption of #Drug2 can be decreased when combined with #Drug1., and the side effect of having Drug 2 with Drug 1 is acute pancreatitis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Telithromycinis given by CSS - 4.732896327972412, Synergy - 0.3588543236255646, ZIP - 0.16607773303985596, LOEWE - -0.3808203935623169, HSA - 0.33911415934562683 and BLISS - 0.07386884838342667. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and manidipine is #Drug1 may decrease the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acromegaly. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and manidipineis given by CSS - 6.450122833251953, Synergy - 0.10679341107606888, ZIP - 0.19856829941272736, LOEWE - -0.5287380814552307, HSA - 0.43047213554382324 and BLISS - 0.08155734091997147. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Esomeprazole is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Esomeprazoleis given by CSS - 10.698416709899902, Synergy - -0.4710472822189331, ZIP - 0.27673524618148804, LOEWE - -0.7553108334541321, HSA - 0.6653653383255005 and BLISS - 0.13959191739559174. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and erythromycin is #Drug1 may decrease the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acromegaly. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and erythromycinis given by CSS - 5.6233038902282715, Synergy - 0.23096603155136108, ZIP - 0.18297810852527618, LOEWE - -0.46278709173202515, HSA - 0.3862808048725128 and BLISS - 0.07694865018129349. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Boceprevir is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Bocepreviris given by CSS - 7.795658588409424, Synergy - -0.10796523094177246, ZIP - 0.22359056770801544, LOEWE - -0.6180034875869751, HSA - 0.503792405128479 and BLISS - 0.09522394835948944. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Nilotinib is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Nilotinibis given by CSS - 7.416380405426025, Synergy - -0.04801523685455322, ZIP - 0.21658706665039062, LOEWE - -0.594893753528595, HSA - 0.48292112350463867 and BLISS - 0.09048029035329819. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and sulfadiazine is #Drug1 may increase the ototoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is abscess. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and sulfadiazineis given by CSS - 12.275577545166016, Synergy - -0.6021105647087097, ZIP - 0.3055875301361084, LOEWE - -0.8078922033309937, HSA - 0.7531914114952087 and BLISS - 0.16392171382904053. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and itraconazole is #Drug1 may decrease the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acromegaly. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and itraconazoleis given by CSS - 5.889526844024658, Synergy - 0.19171938300132751, ZIP - 0.18801166117191315, LOEWE - -0.48503434658050537, HSA - 0.4004558324813843 and BLISS - 0.0781944990158081. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and rosiglitazone is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and rosiglitazoneis given by CSS - 10.473078727722168, Synergy - -0.4490879774093628, ZIP - 0.2726123332977295, LOEWE - -0.7467055320739746, HSA - 0.6528162956237793 and BLISS - 0.1361154317855835. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and doxycycline is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and doxycyclineis given by CSS - 8.895502090454102, Synergy - -0.2676088809967041, ZIP - 0.2437441349029541, LOEWE - -0.6773662567138672, HSA - 0.5649555921554565 and BLISS - 0.11177443712949753. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and ceritinib is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and ceritinibis given by CSS - 7.601211071014404, Synergy - -0.07746672630310059, ZIP - 0.22000494599342346, LOEWE - -0.606343150138855, HSA - 0.49307188391685486 and BLISS - 0.09270337224006653. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Abiraterone is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Abirateroneis given by CSS - 10.247733116149902, Synergy - -0.4262169599533081, ZIP - 0.26848918199539185, LOEWE - -0.7377973794937134, HSA - 0.6402666568756104 and BLISS - 0.13263875246047974. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and fusidic acid is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and fusidic acidis given by CSS - 7.795658588409424, Synergy - -0.10796523094177246, ZIP - 0.22359056770801544, LOEWE - -0.6180034875869751, HSA - 0.503792405128479 and BLISS - 0.09522394835948944. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and No common name found is The absorption of #Drug2 can be decreased when combined with #Drug1., and the side effect of having Drug 2 with Drug 1 is acute pancreatitis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and No common name foundis given by CSS - 5.492713451385498, Synergy - 0.25001269578933716, ZIP - 0.18050509691238403, LOEWE - -0.45150697231292725, HSA - 0.3793424367904663 and BLISS - 0.07640374451875687. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Palbociclib is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Palbociclibis given by CSS - 8.67010498046875, Synergy - -0.23720240592956543, ZIP - 0.2396189421415329, LOEWE - -0.6660181879997253, HSA - 0.5524014830589294 and BLISS - 0.10829634219408035. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Ivacaftor is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Ivacaftoris given by CSS - 9.571651458740234, Synergy - -0.35174643993377686, ZIP - 0.25611793994903564, LOEWE - -0.7091479301452637, HSA - 0.6026139259338379 and BLISS - 0.12220750749111176. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Aprepitant is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Aprepitantis given by CSS - 7.795658588409424, Synergy - -0.10796523094177246, ZIP - 0.22359056770801544, LOEWE - -0.6180034875869751, HSA - 0.503792405128479 and BLISS - 0.09522394835948944. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Netupitant is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Netupitantis given by CSS - 7.070778846740723, Synergy - 0.008157914504408836, ZIP - 0.21017087996006012, LOEWE - -0.5724844336509705, HSA - 0.46404510736465454 and BLISS - 0.08677846193313599. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and tamoxifen is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and tamoxifenis given by CSS - 9.797019958496094, Synergy - -0.3775864243507385, ZIP - 0.2602419853210449, LOEWE - -0.7190299034118652, HSA - 0.6151654124259949 and BLISS - 0.12568478286266327. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Pioglitazone is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Pioglitazoneis given by CSS - 10.473078727722168, Synergy - -0.4490879774093628, ZIP - 0.2726123332977295, LOEWE - -0.7467055320739746, HSA - 0.6528162956237793 and BLISS - 0.1361154317855835. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Idelalisib is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Idelalisibis given by CSS - 9.120893478393555, Synergy - -0.29680323600769043, ZIP - 0.24786902964115143, LOEWE - -0.6883286237716675, HSA - 0.5775089859962463 and BLISS - 0.11525233834981918. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and clemastine is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and clemastineis given by CSS - 10.698416709899902, Synergy - -0.4710472822189331, ZIP - 0.27673524618148804, LOEWE - -0.7553108334541321, HSA - 0.6653653383255005 and BLISS - 0.13959191739559174. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and floxuridine is #Drug1 may increase the ototoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is abscess. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and floxuridineis given by CSS - 12.275577545166016, Synergy - -0.6021105647087097, ZIP - 0.3055875301361084, LOEWE - -0.8078922033309937, HSA - 0.7531914114952087 and BLISS - 0.16392171382904053. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and modafinil is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and modafinilis given by CSS - 11.824996948242188, Synergy - -0.5683897733688354, ZIP - 0.2973453998565674, LOEWE - -0.7941439151763916, HSA - 0.7281013131141663 and BLISS - 0.15697133541107178. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Fosaprepitant is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Fosaprepitantis given by CSS - 7.070778846740723, Synergy - 0.008157914504408836, ZIP - 0.21017087996006012, LOEWE - -0.5724844336509705, HSA - 0.46404510736465454 and BLISS - 0.08677846193313599. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Bortezomib is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Bortezomibis given by CSS - 9.797019958496094, Synergy - -0.3775864243507385, ZIP - 0.2602419853210449, LOEWE - -0.7190299034118652, HSA - 0.6151654124259949 and BLISS - 0.12568478286266327. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and nicotine is #Drug1 may increase the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is premature separation of placenta. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and nicotineis given by CSS - 13.40190315246582, Synergy - -0.6753307580947876, ZIP - 0.3261879086494446, LOEWE - -0.8383771181106567, HSA - 0.8159061074256897 and BLISS - 0.1812942624092102. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and diltiazem is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and diltiazemis given by CSS - 9.571651458740234, Synergy - -0.35174643993377686, ZIP - 0.25611793994903564, LOEWE - -0.7091479301452637, HSA - 0.6026139259338379 and BLISS - 0.12220750749111176. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and cyclosporin A is #Drug1 may increase the central nervous system depressant (CNS depressant) activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is adjustment disorder. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and cyclosporin Ais given by CSS - 2.305375576019287, Synergy - 0.5939732789993286, ZIP - 0.11676676571369171, LOEWE - -0.08783167600631714, HSA - 0.20841294527053833 and BLISS - 0.06508515775203705. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Dosulepin is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Dosulepinis given by CSS - 11.374387741088867, Synergy - -0.5318107604980469, ZIP - 0.2891021966934204, LOEWE - -0.7794111967086792, HSA - 0.7030088305473328 and BLISS - 0.15002015233039856. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and losartan is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and losartanis given by CSS - 9.34627628326416, Synergy - -0.32483363151550293, ZIP - 0.25199365615844727, LOEWE - -0.6989182233810425, HSA - 0.5900617837905884 and BLISS - 0.11873001605272293. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Luliconazole is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Luliconazoleis given by CSS - 11.374387741088867, Synergy - -0.5318107604980469, ZIP - 0.2891021966934204, LOEWE - -0.7794111967086792, HSA - 0.7030088305473328 and BLISS - 0.15002015233039856. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and clarithromycin is The absorption of #Drug2 can be decreased when combined with #Drug1., and the side effect of having Drug 2 with Drug 1 is acute pancreatitis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and clarithromycinis given by CSS - 5.492713451385498, Synergy - 0.25001269578933716, ZIP - 0.18050509691238403, LOEWE - -0.45150697231292725, HSA - 0.3793424367904663 and BLISS - 0.07640374451875687. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and mifepristone is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and mifepristoneis given by CSS - 8.895502090454102, Synergy - -0.2676088809967041, ZIP - 0.2437441349029541, LOEWE - -0.6773662567138672, HSA - 0.5649555921554565 and BLISS - 0.11177443712949753. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and efavirenz is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and efavirenzis given by CSS - 11.374387741088867, Synergy - -0.5318107604980469, ZIP - 0.2891021966934204, LOEWE - -0.7794111967086792, HSA - 0.7030088305473328 and BLISS - 0.15002015233039856. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and zafirlukast is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and zafirlukastis given by CSS - 7.070778846740723, Synergy - 0.008157914504408836, ZIP - 0.21017087996006012, LOEWE - -0.5724844336509705, HSA - 0.46404510736465454 and BLISS - 0.08677846193313599. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and 5-Fluorouracil is #Drug1 may increase the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is premature separation of placenta. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and 5-Fluorouracilis given by CSS - 14.07761287689209, Synergy - -0.7126245498657227, ZIP - 0.3385447859764099, LOEWE - -0.8542929887771606, HSA - 0.8535277247428894 and BLISS - 0.19171543419361115. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Fluvoxamine, (Z)- is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Fluvoxamine, (Z)-is given by CSS - 11.149070739746094, Synergy - -0.5123744606971741, ZIP - 0.2849801480770111, LOEWE - -0.771653950214386, HSA - 0.6904615759849548 and BLISS - 0.14654427766799927. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and sulfisoxazole is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and sulfisoxazoleis given by CSS - 12.050292015075684, Synergy - -0.5855931043624878, ZIP - 0.30146658420562744, LOEWE - -0.80113685131073, HSA - 0.7406467199325562 and BLISS - 0.1604466289281845. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Voriconazole is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Voriconazoleis given by CSS - 10.473078727722168, Synergy - -0.4490879774093628, ZIP - 0.2726123332977295, LOEWE - -0.7467055320739746, HSA - 0.6528162956237793 and BLISS - 0.1361154317855835. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and ticlopidine is #Drug1 may increase the ototoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is abscess. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and ticlopidineis given by CSS - 12.275577545166016, Synergy - -0.6021105647087097, ZIP - 0.3055875301361084, LOEWE - -0.8078922033309937, HSA - 0.7531914114952087 and BLISS - 0.16392171382904053. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Lobeglitazone is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Lobeglitazoneis given by CSS - 8.44469928741455, Synergy - -0.2055332064628601, ZIP - 0.235493466258049, LOEWE - -0.6542707681655884, HSA - 0.5398468375205994 and BLISS - 0.10481804609298706. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and indinavir is #Drug1 may decrease the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acromegaly. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and indinaviris given by CSS - 6.450122833251953, Synergy - 0.10679341107606888, ZIP - 0.19856829941272736, LOEWE - -0.5287380814552307, HSA - 0.43047213554382324 and BLISS - 0.08155734091997147. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and lovastatin is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and lovastatinis given by CSS - 9.571651458740234, Synergy - -0.35174643993377686, ZIP - 0.25611793994903564, LOEWE - -0.7091479301452637, HSA - 0.6026139259338379 and BLISS - 0.12220750749111176. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and CAPECITABINE is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and CAPECITABINEis given by CSS - 10.473078727722168, Synergy - -0.4490879774093628, ZIP - 0.2726123332977295, LOEWE - -0.7467055320739746, HSA - 0.6528162956237793 and BLISS - 0.1361154317855835. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and fluconazole is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and fluconazoleis given by CSS - 11.149070739746094, Synergy - -0.5123744606971741, ZIP - 0.2849801480770111, LOEWE - -0.771653950214386, HSA - 0.6904615759849548 and BLISS - 0.14654427766799927. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and pantoprazole is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and pantoprazoleis given by CSS - 10.247733116149902, Synergy - -0.4262169599533081, ZIP - 0.26848918199539185, LOEWE - -0.7377973794937134, HSA - 0.6402666568756104 and BLISS - 0.13263875246047974. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and clotrimazole is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and clotrimazoleis given by CSS - 10.473078727722168, Synergy - -0.4490879774093628, ZIP - 0.2726123332977295, LOEWE - -0.7467055320739746, HSA - 0.6528162956237793 and BLISS - 0.1361154317855835. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and VALPROIC ACID is #Drug1 may increase the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is premature separation of placenta. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and VALPROIC ACIDis given by CSS - 13.852383613586426, Synergy - -0.7006953954696655, ZIP - 0.3344261050224304, LOEWE - -0.8491700291633606, HSA - 0.8409877419471741 and BLISS - 0.1882418990135193. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and osimertinib is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and osimertinibis given by CSS - 7.795658588409424, Synergy - -0.10796523094177246, ZIP - 0.22359056770801544, LOEWE - -0.6180034875869751, HSA - 0.503792405128479 and BLISS - 0.09522394835948944. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and STIRIPENTOL is #Drug1 may increase the ototoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is abscess. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and STIRIPENTOLis given by CSS - 12.275577545166016, Synergy - -0.6021105647087097, ZIP - 0.3055875301361084, LOEWE - -0.8078922033309937, HSA - 0.7531914114952087 and BLISS - 0.16392171382904053. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and fluvastatin is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and fluvastatinis given by CSS - 9.34627628326416, Synergy - -0.32483363151550293, ZIP - 0.25199365615844727, LOEWE - -0.6989182233810425, HSA - 0.5900617837905884 and BLISS - 0.11873001605272293. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and trimethoprim is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and trimethoprimis given by CSS - 11.374387741088867, Synergy - -0.5318107604980469, ZIP - 0.2891021966934204, LOEWE - -0.7794111967086792, HSA - 0.7030088305473328 and BLISS - 0.15002015233039856. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Lumacaftor is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Lumacaftoris given by CSS - 8.67010498046875, Synergy - -0.23720240592956543, ZIP - 0.2396189421415329, LOEWE - -0.6660181879997253, HSA - 0.5524014830589294 and BLISS - 0.10829634219408035. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Dronedarone is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Dronedaroneis given by CSS - 7.416380405426025, Synergy - -0.04801523685455322, ZIP - 0.21658706665039062, LOEWE - -0.594893753528595, HSA - 0.48292112350463867 and BLISS - 0.09048029035329819. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and RANOLAZINE is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and RANOLAZINEis given by CSS - 9.120893478393555, Synergy - -0.29680323600769043, ZIP - 0.24786902964115143, LOEWE - -0.6883286237716675, HSA - 0.5775089859962463 and BLISS - 0.11525233834981918. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and felodipine is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and felodipineis given by CSS - 10.473078727722168, Synergy - -0.4490879774093628, ZIP - 0.2726123332977295, LOEWE - -0.7467055320739746, HSA - 0.6528162956237793 and BLISS - 0.1361154317855835. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Eslicarbazepine acetate is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Eslicarbazepine acetateis given by CSS - 11.149070739746094, Synergy - -0.5123744606971741, ZIP - 0.2849801480770111, LOEWE - -0.771653950214386, HSA - 0.6904615759849548 and BLISS - 0.14654427766799927. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Olaparib is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Olaparibis given by CSS - 8.895502090454102, Synergy - -0.2676088809967041, ZIP - 0.2437441349029541, LOEWE - -0.6773662567138672, HSA - 0.5649555921554565 and BLISS - 0.11177443712949753. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Sorafenib is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Sorafenibis given by CSS - 8.895502090454102, Synergy - -0.2676088809967041, ZIP - 0.2437441349029541, LOEWE - -0.6773662567138672, HSA - 0.5649555921554565 and BLISS - 0.11177443712949753. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and cimetidine is #Drug1 may increase the ototoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is abscess. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and cimetidineis given by CSS - 12.275577545166016, Synergy - -0.6021105647087097, ZIP - 0.3055875301361084, LOEWE - -0.8078922033309937, HSA - 0.7531914114952087 and BLISS - 0.16392171382904053. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of trimethadione for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between trimethadione and Dasatinib is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of trimethadione in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between trimethadione and Dasatinibis given by CSS - 8.67010498046875, Synergy - -0.23720240592956543, ZIP - 0.2396189421415329, LOEWE - -0.6660181879997253, HSA - 0.5524014830589294 and BLISS - 0.10829634219408035. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of doxorubicin for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between doxorubicin and palmitic acid is #Drug1 may decrease the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acromegaly. The solubility of doxorubicin in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between doxorubicin and palmitic acidis given by CSS - 47.86067199707031, Synergy - -0.9939737319946289, ZIP - 1.0261304378509521, LOEWE - -0.999235987663269, HSA - 2.7560436725616455 and BLISS - 0.5599750280380249. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of 001, RAD for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between 001, RAD and palmitic acid is #Drug1 may increase the cardiotoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is adenoma. The solubility of 001, RAD in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between 001, RAD and palmitic acidis given by CSS - 82.33436584472656, Synergy - -0.9999088048934937, ZIP - 1.7008435726165771, LOEWE - -0.9999967217445374, HSA - 4.661958694458008 and BLISS - 0.9257398843765259. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Ledipasvir for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between Ledipasvir and palmitic acid is #Drug1 may increase the cardiotoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is adenoma. The solubility of Ledipasvir in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Ledipasvir and palmitic acidis given by CSS - 78.77542877197266, Synergy - -0.9998593330383301, ZIP - 1.6313196420669556, LOEWE - -0.9999942779541016, HSA - 4.465401649475098 and BLISS - 0.8880867958068848. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Naloxegol for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between Naloxegol and palmitic acid is #Drug1 may decrease the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acromegaly. The solubility of Naloxegol in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Naloxegol and palmitic acidis given by CSS - 56.20695114135742, Synergy - -0.9978101849555969, ZIP - 1.189931035041809, LOEWE - -0.99979567527771, HSA - 3.218165636062622 and BLISS - 0.6488957405090332. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Rifaximin for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between Rifaximin and palmitic acid is #Drug1 may decrease the bronchodilatory activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is adenocarcinoma. The solubility of Rifaximin in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Rifaximin and palmitic acidis given by CSS - 69.28105926513672, Synergy - -0.9995532631874084, ZIP - 1.4457776546478271, LOEWE - -0.9999741911888123, HSA - 3.9409267902374268 and BLISS - 0.7875806093215942. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Silodosin for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between Silodosin and palmitic acid is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of Silodosin in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Silodosin and palmitic acidis given by CSS - 43.073524475097656, Synergy - -0.9892477989196777, ZIP - 0.9318622350692749, LOEWE - -0.998374342918396, HSA - 2.4905030727386475 and BLISS - 0.5087124109268188. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Pazopanib for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between Pazopanib and palmitic acid is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of Pazopanib in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Pazopanib and palmitic acidis given by CSS - 38.26570510864258, Synergy - -0.9808040261268616, ZIP - 0.8368206024169922, LOEWE - -0.9965351223945618, HSA - 2.2232625484466553 and BLISS - 0.45692768692970276. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of topotecan for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between topotecan and palmitic acid is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of topotecan in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between topotecan and palmitic acidis given by CSS - 38.26570510864258, Synergy - -0.9808040261268616, ZIP - 0.8368206024169922, LOEWE - -0.9965351223945618, HSA - 2.2232625484466553 and BLISS - 0.45692768692970276. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Prucalopride for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between Prucalopride and palmitic acid is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of Prucalopride in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Prucalopride and palmitic acidis given by CSS - 30.993085861206055, Synergy - -0.9541264176368713, ZIP - 0.6919811964035034, LOEWE - -0.9891666173934937, HSA - 1.8174058198928833 and BLISS - 0.37771233916282654. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of vincristine for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between vincristine and palmitic acid is #Drug1 may decrease the bronchodilatory activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is adenocarcinoma. The solubility of vincristine in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between vincristine and palmitic acidis given by CSS - 72.84229278564453, Synergy - -0.9997103810310364, ZIP - 1.5153874158859253, LOEWE - -0.9999853372573853, HSA - 4.137674808502197 and BLISS - 0.8252917528152466. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Afatinib for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between Afatinib and palmitic acid is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of Afatinib in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Afatinib and palmitic acidis given by CSS - 41.87382125854492, Synergy - -0.9875720739364624, ZIP - 0.9081859588623047, LOEWE - -0.9980360865592957, HSA - 2.423877716064453 and BLISS - 0.49582305550575256. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of EDOXABAN for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between EDOXABAN and palmitic acid is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of EDOXABAN in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between EDOXABAN and palmitic acidis given by CSS - 45.46921157836914, Synergy - -0.9919509291648865, ZIP - 0.9790756106376648, LOEWE - -0.9988857507705688, HSA - 2.6234476566314697 and BLISS - 0.5343971252441406. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Bosutinib for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between Bosutinib and palmitic acid is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of Bosutinib in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Bosutinib and palmitic acidis given by CSS - 44.271949768066406, Synergy - -0.9906971454620361, ZIP - 0.9554906487464905, LOEWE - -0.9986541867256165, HSA - 2.557023286819458 and BLISS - 0.5215694904327393. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of RANOLAZINE for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between RANOLAZINE and palmitic acid is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of RANOLAZINE in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between RANOLAZINE and palmitic acidis given by CSS - 38.26570510864258, Synergy - -0.9808040261268616, ZIP - 0.8368206024169922, LOEWE - -0.9965351223945618, HSA - 2.2232625484466553 and BLISS - 0.45692768692970276. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of (R/S)-Colchicine for >sp|P15090|FABP4_HUMAN Fatty acid-binding protein, adipocyte OS=Homo sapiens OX=9606 GN=FABP4 PE=1 SV=3\n","MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN\n","TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM\n","KGVTSTRVYERA\n"," is 0.5560332536697388. The Drug-Drug Interaction between (R/S)-Colchicine and palmitic acid is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of (R/S)-Colchicine in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between (R/S)-Colchicine and palmitic acidis given by CSS - 35.8512077331543, Synergy - -0.9743432402610779, ZIP - 0.788903534412384, LOEWE - -0.9949373602867126, HSA - 2.0887722969055176 and BLISS - 0.4307677447795868. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of carbamazepine for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between carbamazepine and trimethadione is #Drug1 may increase the ototoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is abscess. The solubility of carbamazepine in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between carbamazepine and trimethadioneis given by CSS - 24.136150360107422, Synergy - -0.907966136932373, ZIP - 0.5494450330734253, LOEWE - -0.9685030579566956, HSA - 1.4299876689910889 and BLISS - 0.30867481231689453. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of RIFAPENTINE for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between RIFAPENTINE and trimethadione is The absorption of #Drug2 can be decreased when combined with #Drug1., and the side effect of having Drug 2 with Drug 1 is acute pancreatitis. The solubility of RIFAPENTINE in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between RIFAPENTINE and trimethadioneis given by CSS - 78.17894744873047, Synergy - -0.9998642802238464, ZIP - 1.6169477701187134, LOEWE - -0.9999936819076538, HSA - 4.432560443878174 and BLISS - 0.8901013135910034. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of nevirapine for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between nevirapine and trimethadione is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of nevirapine in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between nevirapine and trimethadioneis given by CSS - 26.628625869750977, Synergy - -0.9313024282455444, ZIP - 0.6002731919288635, LOEWE - -0.9785759449005127, HSA - 1.5708503723144531 and BLISS - 0.33680227398872375. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of primidone for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between primidone and trimethadione is #Drug1 may increase the ototoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is abscess. The solubility of primidone in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between primidone and trimethadioneis given by CSS - 21.61822509765625, Synergy - -0.8766076564788818, ZIP - 0.4976673126220703, LOEWE - -0.9536011219024658, HSA - 1.287050724029541 and BLISS - 0.279904842376709. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of secobarbital for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between secobarbital and trimethadione is #Drug1 may increase the ototoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is abscess. The solubility of secobarbital in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between secobarbital and trimethadioneis given by CSS - 22.88068199157715, Synergy - -0.8934454321861267, ZIP - 0.5236864686012268, LOEWE - -0.9617819786071777, HSA - 1.3588037490844727 and BLISS - 0.2943779528141022. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of phenobarbital for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between phenobarbital and trimethadione is #Drug1 may increase the ototoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is abscess. The solubility of phenobarbital in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between phenobarbital and trimethadioneis given by CSS - 22.88068199157715, Synergy - -0.8934454321861267, ZIP - 0.5236864686012268, LOEWE - -0.9617819786071777, HSA - 1.3588037490844727 and BLISS - 0.2943779528141022. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Rifampicin for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between Rifampicin and trimethadione is The absorption of #Drug2 can be decreased when combined with #Drug1., and the side effect of having Drug 2 with Drug 1 is acute pancreatitis. The solubility of Rifampicin in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Rifampicin and trimethadioneis given by CSS - 73.43192291259766, Synergy - -0.9997581243515015, ZIP - 1.524182677268982, LOEWE - -0.9999865293502808, HSA - 4.17033576965332 and BLISS - 0.8398523330688477. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Fosphenytoin for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between Fosphenytoin and trimethadione is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of Fosphenytoin in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Fosphenytoin and trimethadioneis given by CSS - 32.77560043334961, Synergy - -0.9668466448783875, ZIP - 0.7242003083229065, LOEWE - -0.9917705059051514, HSA - 1.9161332845687866 and BLISS - 0.4049953818321228. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Pregabalin for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between Pregabalin and trimethadione is #Drug1 may increase the anticoagulant activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is premature separation of placenta. The solubility of Pregabalin in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Pregabalin and trimethadioneis given by CSS - 15.174129486083984, Synergy - -0.7420046329498291, ZIP - 0.3626558184623718, LOEWE - -0.8763431310653687, HSA - 0.9175611734390259 and BLISS - 0.20421165227890015. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of mefloquine for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between mefloquine and trimethadione is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of mefloquine in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between mefloquine and trimethadioneis given by CSS - 33.99382019042969, Synergy - -0.9713325500488281, ZIP - 0.7485684156417847, LOEWE - -0.9931977987289429, HSA - 1.984276294708252 and BLISS - 0.4183519184589386. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Conivaptan for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between Conivaptan and trimethadione is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of Conivaptan in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Conivaptan and trimethadioneis given by CSS - 48.44355392456055, Synergy - -0.9949659705162048, ZIP - 1.0346736907958984, LOEWE - -0.9992989301681519, HSA - 2.7881479263305664 and BLISS - 0.5743664503097534. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Enzalutamide for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between Enzalutamide and trimethadione is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of Enzalutamide in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Enzalutamide and trimethadioneis given by CSS - 41.249576568603516, Synergy - -0.9879978895187378, ZIP - 0.8927758932113647, LOEWE - -0.9978215098381042, HSA - 2.388747453689575 and BLISS - 0.4971388876438141. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Deferasirox for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between Deferasirox and trimethadione is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of Deferasirox in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Deferasirox and trimethadioneis given by CSS - 36.42164993286133, Synergy - -0.9785599708557129, ZIP - 0.796983003616333, LOEWE - -0.9953495264053345, HSA - 2.1198575496673584 and BLISS - 0.44484758377075195. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Vemurafenib for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between Vemurafenib and trimethadione is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of Vemurafenib in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Vemurafenib and trimethadioneis given by CSS - 42.45193862915039, Synergy - -0.9896169900894165, ZIP - 0.9165514707565308, LOEWE - -0.998197078704834, HSA - 2.4555909633636475 and BLISS - 0.5100952386856079. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of CYPROTERONE ACETATE for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between CYPROTERONE ACETATE and trimethadione is #Drug1 may increase the hypoglycemic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is Acidosis. The solubility of CYPROTERONE ACETATE in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between CYPROTERONE ACETATE and trimethadioneis given by CSS - 37.631771087646484, Synergy - -0.981456458568573, ZIP - 0.8210484981536865, LOEWE - -0.9961535930633545, HSA - 2.187337636947632 and BLISS - 0.4579996168613434. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Bosentan for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between Bosentan and trimethadione is The serum concentration of the active metabolites of #Drug2 can be reduced when #Drug2 is used in combination with #Drug1 resulting in a loss in efficacy., and the side effect of having Drug 2 with Drug 1 is acquired immune deficiency syndrome. The solubility of Bosentan in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Bosentan and trimethadioneis given by CSS - 49.638641357421875, Synergy - -0.9956440925598145, ZIP - 1.05817711353302, LOEWE - -0.9994194507598877, HSA - 2.8543930053710938 and BLISS - 0.5871390104293823. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of mitotane for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between mitotane and trimethadione is #Drug1 may increase the ototoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is abscess. The solubility of mitotane in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between mitotane and trimethadioneis given by CSS - 24.136150360107422, Synergy - -0.907966136932373, ZIP - 0.5494450330734253, LOEWE - -0.9685030579566956, HSA - 1.4299876689910889 and BLISS - 0.30867481231689453. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of mianserin for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between mianserin and trimethadione is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of mianserin in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between mianserin and trimethadioneis given by CSS - 26.628625869750977, Synergy - -0.9313024282455444, ZIP - 0.6002731919288635, LOEWE - -0.9785759449005127, HSA - 1.5708503723144531 and BLISS - 0.33680227398872375. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of CHEBI:45367 for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between CHEBI:45367 and trimethadione is The absorption of #Drug2 can be decreased when combined with #Drug1., and the side effect of having Drug 2 with Drug 1 is acute pancreatitis. The solubility of CHEBI:45367 in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between CHEBI:45367 and trimethadioneis given by CSS - 75.8056411743164, Synergy - -0.9998188018798828, ZIP - 1.570573329925537, LOEWE - -0.9999907612800598, HSA - 4.3014655113220215 and BLISS - 0.8649821281433105. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of phenytoin for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between phenytoin and trimethadione is The therapeutic efficacy of #Drug2 can be increased when used in combination with #Drug1., and the side effect of having Drug 2 with Drug 1 is acanthosis nigricans. The solubility of phenytoin in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between phenytoin and trimethadioneis given by CSS - 25.385272979736328, Synergy - -0.9204927682876587, ZIP - 0.5749667882919312, LOEWE - -0.9740291833877563, HSA - 1.5006544589996338 and BLISS - 0.32281139492988586. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of pentobarbital for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between pentobarbital and trimethadione is #Drug1 may increase the ototoxic activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is abscess. The solubility of pentobarbital in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between pentobarbital and trimethadioneis given by CSS - 21.61822509765625, Synergy - -0.8766076564788818, ZIP - 0.4976673126220703, LOEWE - -0.9536011219024658, HSA - 1.287050724029541 and BLISS - 0.279904842376709. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of orlistat for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between orlistat and trimethadione is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of orlistat in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between orlistat and trimethadioneis given by CSS - 44.85224914550781, Synergy - -0.9922283291816711, ZIP - 0.9639374613761902, LOEWE - -0.99876469373703, HSA - 2.5889151096343994 and BLISS - 0.5358961820602417. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n","I am a patient. These are the lab results - The effectiveness of Dabrafenib for >sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2\n","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL\n","NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL\n","VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP\n","RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM\n","VDNWRPAQPLKNRQIKASFK\n"," is 4.489902019500732. The Drug-Drug Interaction between Dabrafenib and trimethadione is #Drug1 may increase the antihypertensive activities of #Drug2., and the side effect of having Drug 2 with Drug 1 is renal tubular acidosis. The solubility of Dabrafenib in water is -0.3353900909423828. CSS measures the drug combination sensitivity and is derived using relative IC50 values of compoundsand the area under their dose-response curves. The other four metrics capture the synergy between thetwo drugs. Synergy is a dimensionless measure of deviation of an observed drug combination response fromthe expected effect of non-interaction. Synergy is calculated using four different models: Bliss model, Highest Single Agent (HSA),Loewe additivity model and Zero Interaction Potency (ZIP).The synergy between Dabrafenib and trimethadioneis given by CSS - 44.85224914550781, Synergy - -0.9922283291816711, ZIP - 0.9639374613761902, LOEWE - -0.99876469373703, HSA - 2.5889151096343994 and BLISS - 0.5358961820602417. \n","In the report, make sure to incorporate the effect on drug effectiveness from all these interactions.\n","\n","\n","\n","\n"]}]}]}